Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Other financing activities (2021 - 2023)

Celularity has reported Other financing activities over the past 3 years, most recently at $260000.0 for Q3 2023.

  • Quarterly results put Other financing activities at $260000.0 for Q3 2023, up 12.55% from a year ago — trailing twelve months through Dec 2023 was $341000.0 (down 93.32% YoY), and the annual figure for FY2023 was $1.6 million, down 40.36%.
  • Other financing activities for Q3 2023 was $260000.0 at Celularity, up from -$150000.0 in the prior quarter.
  • Over the last five years, Other financing activities for CELU hit a ceiling of $4.8 million in Q1 2021 and a floor of -$150000.0 in Q4 2022.
  • Median Other financing activities over the past 3 years was $999000.0 (2021), compared with a mean of $1.6 million.
  • Biggest five-year swings in Other financing activities: tumbled 110.5% in 2022 and later grew 12.55% in 2023.
  • Celularity's Other financing activities stood at $1.4 million in 2021, then plummeted by 110.5% to -$150000.0 in 2022, then skyrocketed by 273.33% to $260000.0 in 2023.
  • The last three reported values for Other financing activities were $260000.0 (Q3 2023), -$150000.0 (Q4 2022), and $231000.0 (Q3 2022) per Business Quant data.